Grimsbys Labor Market Challenge A Young Job Seekers Fight Amid Worklessness Stigma Yardeni Warns Fed May Need July Rate Hike to Appease Bond Vigilantes Amid Incoming Chair Warshs Dilemma Jobless Claims Remain Near Historic Lows Signaling Resilient Labor Market Memory Chip Supply Constraints Impact Major Chinese Automakers AI Stocks Poised for Growth Beyond Initial Rally BP Removes Chair Albert Manifold Over Governance and Conduct Concerns BCC Q1 2026 Earnings EPS Surges Past Estimates with 1826 Surprise XPRO Q1 2026 Earnings EPS Misses Estimates Amid Challenging Conditions Harmonic HLIT Q1 2026 Earnings EPS Shatters Estimates Stock Surges BLMN Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency AZZ Inc AZZ Q1 2026 Earnings EPS Beat Amid Solid Execution Revenue Details Not Disclosed MBIA Q1 2026 Earnings Deep Losses Underscore Continued Credit Portfolio Challenges Roper Technologies ROP Holds Near Key Support as Shares Edge Higher PS International Group PSIG Surges 183 as Stock Tests Key Resistance Level at 82 Core Scientific Warrants CORZZ Surge 281 as Sentiment Shifts in Bitcoin Mining Sector TPG RE Finance Trust TRTX Holds Steady Near Support as Commercial Real Estate Sentiment Shifts Radiopharm Theranostics RADX Gains Ground Testing Key Resistance at 485 Cryptocurrency Market Faces Renewed Volatility as Bitcoin and Ethereum Decline Amid Macroeconomic and Geopolitical Headwinds P3 Health Partners Inc PIII Q1 2026 Earnings Surprise Profit Beats Heavy Loss Estimate Yet Stock Declines Duolingo Inc DUOL Edges Higher as Stock Consolidates Near Key Levels Honeywell International HON Edges Higher as Investors Eye Key Resistance Levels UFP Industries UFPI Holds Steady Near 8054 as Consolidation Continues Below Key Resistance Boyd Group Services BGSI Edges Higher as Stock Consolidates Near Support Diamondback Energy FANG Slips 185 as Resistance Holds Support Levels in Focus Vertex Pharmaceuticals VRTX Holds Steady Near Resistance as Volume Signals Caution PriceSmart PSMT Edges Higher Resistance Level in Focus as Stock Holds Above Support Calidi Biotherapeutics CLDI Declines Slightly Approaching Key Support at 016